Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs

BACKGROUND/AIMS: The optimal duration of nucleos(t)ide analogs (NAs) therapy in chronic hepatitis B (CHB) patients remains unsatisfactory. Previous studies have confirmed the important role of host genetic factors in determining the outcome of HBV infection. This study tries to determine the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao, Liu, Feng, Zhang, Lixin, Ye, Qian, Fan, Xiaoping, Xue, Yan, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848322/
https://www.ncbi.nlm.nih.gov/pubmed/29451182
http://dx.doi.org/10.4103/sjg.SJG_228_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848322/
https://www.ncbi.nlm.nih.gov/pubmed/29451182
http://dx.doi.org/10.4103/sjg.SJG_228_17

Ejemplares similares